Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Martin P Vidgeon-Hart"'
Autor:
Caterina Vacchi-Suzzi, Yasmina Bauer, Brian R Berridge, Sandrine Bongiovanni, Kevin Gerrish, Hisham K Hamadeh, Martin Letzkus, Jonathan Lyon, Jonathan Moggs, Richard S Paules, François Pognan, Frank Staedtler, Martin P Vidgeon-Hart, Olivier Grenet, Philippe Couttet
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40395 (2012)
Anti-cancer therapy based on anthracyclines (DNA intercalating Topoisomerase II inhibitors) is limited by adverse effects of these compounds on the cardiovascular system, ultimately causing heart failure. Despite extensive investigations into the eff
Externí odkaz:
https://doaj.org/article/1bf1e6df5257478dabeac3b061a4a4f0
Autor:
Ann M. Williams, Martin P. Vidgeon-Hart, Christopher A. Schofield, Metul Patel, Paul McGill, Carla F. Newman, Justyna M. Macina, Tracy Walker, Maxine A. Taylor, Melanie Z. Sakatis, Denise F. Vlachou
Publikováno v:
Chemical Research in Toxicology. 34:2485-2499
Drug-induced liver injury is a leading cause of compound attrition during both preclinical and clinical drug development, and early strategies are in place to tackle this recurring problem. Human-relevant in vitro models that are more predictive of h
Autor:
Kelly M Gatfield, Miyoung Park, Il-Hong Bae, Martin P. Vidgeon-Hart, Gyeyoung Choi, Jin Kyu Choi, Chang Seok Lee, Angie Burns, Young-Ho Park, Rajni Fagg, Andrew J. Powell, Anita A. Naidoo
Publikováno v:
Cell biology and toxicology. 34(2)
A recent hypothesis suggesting that the pharmacological target TRPV1 (transient receptor potential vanilloid subfamily, member 1) may function as a tumour suppressor, which potentially impacts the development of TRPV1 antagonist therapeutics for a ra
Autor:
Neil Upton, David Virley, Helen Chapman, Martin P. Vidgeon-Hart, Andrew D. Medhurst, Leann P. Quinn, M E Hows, Barry Crook
Publikováno v:
British Journal of Pharmacology. 154:226-233
Background and purpose: The peroxisome proliferator-activated receptor-g (PPARg) agonist pioglitazone has previously been shown to attenuate dopaminergic cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’
Autor:
Neil Upton, Peter L. Woodhams, Helen Chapman, Martin P. Vidgeon-Hart, Marion J. Perren, Menelas N. Pangalos, Leann P. Quinn, David Virley, Kim Brackenborough
Publikováno v:
Journal of Neuroscience Methods. 164:43-49
A beam-walking apparatus has been evaluated for its ability to detect motor impairments in mice acutely treated with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 30 mg/kg, s.c., single or double administration). Mic
Autor:
David C. Grimsditch, Philip Overend, Annette Graham, Suzanne Parkin, Pieter H.E. Groot, G. Martin Benson, Martin P. Vidgeon-Hart, Nuala Murphy
Publikováno v:
Atherosclerosis. 163:69-77
Hyperlipidaemia may accelerate the development of atherosclerosis by enhancing the expression of chemokines by cells within the arterial wall. Chemokines of the CC subfamily are clearly implicated in atherogenesis; however, recent reports suggest tha
Autor:
Brian R. Berridge, Yasmina Bauer, Martin Letzkus, Philippe Couttet, Caterina Vacchi-Suzzi, Kevin Gerrish, Jonathan J. Lyon, Sandrine Bongiovanni, Francois Pognan, Olivier Grenet, Martin P. Vidgeon-Hart, Richard S. Paules, Frank Staedtler, Jonathan G. Moggs, Hisham K. Hamadeh
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e40395 (2012)
PLoS ONE, Vol 7, Iss 7, p e40395 (2012)
Anti-cancer therapy based on anthracyclines (DNA intercalating Topoisomerase II inhibitors) is limited by adverse effects of these compounds on the cardiovascular system, ultimately causing heart failure. Despite extensive investigations into the eff
Autor:
Neil Upton, Simon T. Bate, Marion J. Perren, Flora Joyce, Jill C. Richardson, Tracey Ashmeade, Ainsley A. Culbert, David Virley, David Sunter, Zoe Seymour, Martin P. Vidgeon-Hart, Anna Babin, Perdita L. Pugh
Publikováno v:
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 4, Iss 1, p 8 (2007)
Journal of Neuroinflammation, Vol 4, Iss 1, p 8 (2007)
Background Data indicates anti-oxidant, anti-inflammatory and pro-cognitive properties of noradrenaline and analyses of post-mortem brain of Alzheimer's disease (AD) patients reveal major neuronal loss in the noradrenergic locus coeruleus (LC), the m
Autor:
Mary Vinson, Tania O. Stean, Ian C B Marshall, Martin P. Vidgeon-Hart, Neil Upton, John B. Davis, David C. Harrison, Leann P. Quinn, Stephen A. Burbidge, Elaine A. Irving
Publikováno v:
Alzheimer's & Dementia. 2
Autor:
Ainsley A. Culbert, Perdita L. Pugh, Anna Babin, Simon T. Bate, Martin P. Vidgeon-Hart, Tracey Ashmeade, David Virley, Neil Upton, David Sunter, Zoe Seymour
Publikováno v:
Alzheimer's & Dementia. 2